Novartis AGNVSNYSE
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+40.4%
5Y CAGR+31.9%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+40.4%/yr
Quarterly compound
5Y CAGR
+31.9%/yr
Recent acceleration
Percentile
P97
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.72% |
| Q3 2025 | 2.77% |
| Q2 2025 | 4.46% |
| Q1 2025 | -2.25% |
| Q4 2024 | -1.23% |
| Q3 2024 | 6.17% |
| Q2 2024 | 3.36% |
| Q1 2024 | -9.14% |
| Q4 2023 | -7.87% |
| Q3 2023 | 1.55% |
| Q2 2023 | -1.12% |
| Q1 2023 | -7.82% |
| Q4 2022 | 2.79% |
| Q3 2022 | -3.62% |
| Q2 2022 | -1.84% |
| Q1 2022 | -7.85% |
| Q4 2021 | 12.11% |
| Q3 2021 | -2.26% |
| Q2 2021 | 1.86% |
| Q1 2021 | -7.90% |
| Q4 2020 | 1.94% |
| Q3 2020 | 4.78% |
| Q2 2020 | 0.54% |
| Q1 2020 | 3.96% |
| Q4 2019 | 2.11% |
| Q3 2019 | -0.28% |
| Q2 2019 | -15.70% |
| Q1 2019 | -5.23% |
| Q4 2018 | 1.80% |
| Q3 2018 | 0.66% |
| Q2 2018 | 4.82% |
| Q1 2018 | 1.84% |
| Q4 2017 | -1.40% |
| Q3 2017 | 0.91% |
| Q2 2017 | 1.34% |
| Q1 2017 | 1.43% |
| Q4 2016 | -2.90% |
| Q3 2016 | 1.96% |
| Q2 2016 | -0.76% |
| Q1 2016 | 0.68% |